Aescap Venture is a venture capital company investing in private medical companies in Europe. We help companies to shorten the timelines between invention and introduction of the product. Aescap invests in high-potential companies with realistic product opportunities and the potential to generate cash flow from licensing deals. This involves investments in all phases of development with an emphasis on earlier stages. Aescap Venture's added value is based on a multi-disciplinary team of experienced investment partners. Each has a proven track record of success and the skills to coach entrepreneurs in accelerating the growth of their companies.
For more information see: http://www.aescap.com
Capricorn Venture Partners is a pan-European manager of venture capital funds seeking to invest in technology based growth companies. The Capricorn Cleantech Fund is Capricorn's third consecutive venture capital fund. The fund invests in European growth companies developing innovative breakthrough technologies in the fields of renewable energy and energy efficiency, water purification and re-use, bio based material conversion and biorefinery platforms, clean air, climate change, green chemistry and advanced materials, materials recovery and recycling. The fund benefits from an investment by the European Investment Fund through the "Competitiveness and Innovation Framework Programme" of the European Union.
For more information see: http://www.capricorn.be
About ING Corporate Investments
ING Corporate Investments is a key provider of mezzanine and equity
financing to companies mainly in the Benelux. Its focus is on providing
financial solutions for growth investments, buy-outs, (partial) exits,
recapitalizations and a range of other transactions. ING Corpor
|SOURCE Avantium Technologies B.V.|
Copyright©2008 PR Newswire.
All rights reserved